Our Team
Dr Narelle Hadlow | Chief Executive
Dr Narelle Hadlow, PathWest Chief Executive, is a pathologist with more than 30 years’ experience in clinical and senior administration across public and private pathology sectors. Dr Hadlow has a Bachelor of Medicine and Bachelor of Surgery from the University of Western Australia and is a Fellow of the Royal College of Pathologists of Australasia.
Dr Hadlow was appointed Chief Executive, PathWest, in 2024 and now leads one of the largest public pathology services in the Southern Hemisphere, with a significant sample testing and collection regime and geographical footprint. PathWest delivers more than 14 million tests annually through a statewide network of 30 accredited laboratories and 80 collection centres, providing essential diagnostic, screening and forensic services to support improved diagnoses and health outcomes in metropolitan and regional Western Australia and deliver evidential data to support the justice system. Prior to her appointment, Dr Hadlow was Chief Executive of Clinipath Pathology, where she oversaw significant service expansion, strengthened testing capacity, and led the organisation’s response to COVID-19. Her appointment to Chief Executive roles in Pathology is founded over 20 years in clinical practice as Chemical Pathologist, senior leadership positions in PathWest and academia. With a strong belief in educating trainee doctors and furthering medical research, Dr Hadlow served for a decade as a Clinical Associate Professor at the University of Western Australia, delivering medical education and collaborative research with a central focus on women’s health and endocrinology. With a commitment to delivering high-quality and enhanced access to clinical services for all Western Australians, Dr Hadlow and PathWest senior leaders are delivering digital transformation initiatives. Incorporating the rollout of digital anatomical pathology, digital morphology in haematology and whole-slide imaging across the network, they aim to improve workflows, diagnoses and education across the State.Dr Hadlow’s stewardship of PathWest centres on strengthening statewide integration, clinical governance and service sustainability to meet the evolving health care needs of the WA Community. She also champions recognising and showcasing the expertise of PathWest teams, promoting their contributions locally, nationally and internationally.
Dr Siaw Ming Chai | Acting Chief Pathologist
Dr Siaw Ming Chai completed her Bachelor of Medicine and Bachelor of Surgery (MBBS) and subsequently a Master of Medical Science in Pathology at The University of Western Australia.
She commenced specialist training in Anatomical Pathology in 2004 across PathWest Laboratory Medicine, Princess Margaret Hospital and King Edward Memorial Hospital. In 2008, she was awarded Fellowship of the Royal College of Pathologists of Australasia (RCPA). She further completed a Cytopathology Fellowship at PathWest Laboratory Medicine, QEII Medical Centre, in 2010 and has served as a Consultant Pathologist with PathWest since that time.
Dr Chai’s areas of expertise include Cytopathology, Thoracic Pathology, Endocrine Pathology, Gastrointestinal Pathology and Pancreaticobiliary Pathology. She has contributed extensively to the field through peer-reviewed publications and as a co-author of book chapters in her specialist areas of interest.
A recognised leader in pathology education and professional practice, Dr Chai has served as a Board of Education member and State Councillor for the Western Australian Branch of the Australian Society of Cytology. She is a former member of the RCPA Cytopathology Advisory Committee and has contributed to the development of the RCPA Structured Pathology Reporting of Cancer protocols.
Dr Chai is the former President of the Australasian Gastrointestinal Pathology Society and has previously served as Acting Service Director, Anatomical Pathology, at PathWest Laboratory Medicine. She currently serves as Head of Cytology and Acting Chief Pathologist at PathWest, providing leadership across diagnostic, clinical and professional pathology services.

Sandy Kerr | Executive Director, Finance, Procurement and Commercial Services
Sandy is an experienced leader with more than 18 years’ experience working in the WA State Government.
He has extensive experience in financial management, procurement, organisational development, change management and leading Corporate Services roles including executive level.
Sandy is a Certified Practising Accountant (CPA) Australia member and has performed the role of Chief Financial Officer at a range of WA State Government agencies. Throughout his career Sandy has delivered a range of key reforms that improved the effectiveness of financial controls and budget management.

Paul Schneider | Executive Director, Operations
Paul is a multidisciplinary trained medical scientist with over 30 years’ experience in the pathology industry. He has worked as a scientist in independent and multinational pathology services and progressed to senior and executive management roles, including Chief Scientist and State Manager during his career.
Together with his business partner, he founded and operated a successful independent pathology service from 2006-2017. Paul’s experiences in executive management in the private sector, as well as laboratory owner/operator, provide him with a highly developed knowledge of the Australian pathology industry, pathology business practices and customer-centric pathology services.
Paul is current Vice President and Board Director of Public Pathology Australia (PPA) and has long standing interests in quality management, automation, LIS functionality development and pathology service delivery to customers. He is a NATA assessor and has been a member of various professional scientific and advisory committees locally and nationally. Paul has a Bachelor of Applied Science in Medical Laboratory Science, a Master of Science (Microbiology) by research and professional membership of MAIMS and MASM.

Tim Evans | Chief Technology Officer
Tim has been leveraging technology to support business outcomes for over 20 years.
Tim began his career in the UK financial services before moving into software services. Moving to Australia in 2005, Tim spent more than a decade in the local government sector, leading teams in ICT, governance, risk, strategy, audit, customer services, and contracts.
In 2019, Tim moved to WA Health where he was responsible for the delivery of major ICT projects in the health care sector. Tim holds a Bachelor of Management Science and Master’s degrees in ICT and Business Management (MBA). He also has numerous ICT and project management qualifications and a member of the Australian Institute of Company Directors (AICD).Appointed as the Chief Technology Officer (CTO) in late 2022, Tim is passionate about simplifying business processes and adopting new innovations in the pathology sector.
Jo McCran | Executive Director, People, Capability and Culture
Jo is a HR professional with extensive experience in WA Health. With over 14 years of experience in PathWest, Jo has developed a deep understanding of PathWest and its role in the Western Australian Health System and broader Western Australian community.
Jo holds a Bachelor of Business in Strategic Human Resource Management and a Bachelor of Arts in Psychology.
Throughout her career, Jo has held various roles in the health and banking sectors, which enabled her to develop a broad skill set and a diverse perspective. Her experience includes roles in human resources, management, and operations. Jo is passionate about PathWest and its people, and maintaining the strong professional relationship she has built over time at PathWest and across the WA Health System.
Katherine Galvin | Director, Office of the Chief Executive Kat has considerable experience in navigating highly regulated and fast-paced government policy and operational environments. Kat has a strong commitment to fostering a positive workplace culture as the foundation for a cohesive and effectively performing team.
Kat feels honoured to work for PathWest, valuing its integral role in shaping quality patient service delivery.